| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 32.742 | 53.576 | 63.519 | 66.707 | 68.669 | 76.065 | 94.612 | 107.987 |
| Total Income - EUR | - | - | 32.742 | 53.576 | 63.520 | 66.708 | 68.670 | 76.066 | 94.613 | 107.988 |
| Total Expenses - EUR | - | - | 23.181 | 26.411 | 32.678 | 37.479 | 42.472 | 30.433 | 46.340 | 46.764 |
| Gross Profit/Loss - EUR | - | - | 9.562 | 27.166 | 30.841 | 29.229 | 26.197 | 45.633 | 48.273 | 61.224 |
| Net Profit/Loss - EUR | - | - | 9.234 | 26.630 | 30.206 | 28.587 | 25.510 | 44.872 | 47.327 | 57.984 |
| Employees | - | - | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Medfam Dr Cireaşă Dan George Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 1.977 | 11.680 | 10.117 | 8.492 | 7.460 |
| Current Assets | - | - | 11.452 | 36.423 | 31.395 | 27.745 | 28.625 | 46.765 | 50.194 | 79.535 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 3.214 | 11.284 | 12.161 | 18.992 | 15.012 | 32.967 | 42.061 | 73.644 |
| Cash | - | - | 8.238 | 25.139 | 19.234 | 8.753 | 13.613 | 13.798 | 8.132 | 5.891 |
| Shareholders Funds | - | - | 9.278 | 35.737 | 30.257 | 28.637 | 25.886 | 44.921 | 49.215 | 58.033 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.174 | 685 | 1.138 | 1.085 | 14.419 | 11.961 | 9.471 | 28.962 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medfam Dr Cireaşă Dan George Srl